Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07) Estimate, Sales $1.31M Beat $1.06M Estimate
Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07) Estimate, Sales $1.31M Beat $1.06M Estimate
此外，Therapeutics第四季度每股收益美元（0.70美元）超过预期（1.07美元），销售额131万美元超过106万美元的预期
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(1.07) by 34.58 percent. This is a 70.83 percent increase over losses of $(2.40) per share from the same period last year. The company reported quarterly sales of $1.31 million which beat the analyst consensus estimate of $1.06 million by 23.87 percent. This is a 769.54 percent increase over sales of $151.00 thousand the same period last year.
Plus Therapeutics（纳斯达克股票代码：PSTV）公布的季度亏损为每股0.70美元，比分析师普遍预期的1.07美元（1.07美元）高出34.58％。这比去年同期每股亏损2.40美元（2.40美元）增长了70.83％。该公司公布的季度销售额为131万美元，比分析师普遍预期的106万美元高出23.87％。这比去年同期的15.1万美元的销售额增长了769.54％。